{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:22:45Z","timestamp":1776745365554,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.clbc.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T03:07:27Z","timestamp":1519096047000},"page":"362-373.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1\/2 Mutation Carriers"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0023-7740","authenticated-orcid":false,"given":"Ji Soo","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Woo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Ji","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2018.02.007_bib1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clbc.2018.02.007_bib2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2018.02.007_bib3","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2018.02.007_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clbc.2018.02.007_bib5","author":"NCCN"},{"key":"10.1016\/j.clbc.2018.02.007_bib6","doi-asserted-by":"crossref","first-page":"v103","DOI":"10.1093\/annonc\/mdw327","article-title":"Prevention and screening in BRCA mutation carriers and other breast\/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening","volume":"27","author":"Paluch-Shimon","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2018.02.007_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/WHE.09.42","article-title":"Effect of bilateral oophorectomy on women's long-term health","volume":"5","author":"Parker","year":"2009","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.clbc.2018.02.007_bib8","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1245\/s10434-016-5408-8","article-title":"Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making","volume":"23","author":"Boughey","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2018.02.007_bib9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","volume":"98","author":"Antoniou","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2018.02.007_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw302","article-title":"Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers","volume":"109","author":"Kuchenbaecker","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2018.02.007_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clbc.2018.02.007_bib12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.2014.5985","article-title":"Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer","volume":"313","author":"Rebbeck","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2018.02.007_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bjc.6603535","article-title":"Cancer risks among BRCA1 and BRCA2 mutation carriers","volume":"96","author":"Levy-Lahad","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2018.02.007_bib14","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.18632\/oncotarget.13423","article-title":"The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation","volume":"8","author":"Toss","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2018.02.007_bib15","doi-asserted-by":"crossref","first-page":"D279","DOI":"10.1093\/nar\/gkv1344","article-title":"The Pfam protein families database: towards a more sustainable future (http:\/\/pfam.xfam.org\/)","volume":"44","author":"Finn","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clbc.2018.02.007_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2018.02.007_bib17","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2013.6235","article-title":"Defining \u201cterm\u201d pregnancy: recommendations from the Defining \u201cTerm\u201d Pregnancy Workgroup","volume":"309","author":"Spong","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2018.02.007_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA)","volume":"21","author":"Mavaddat","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2018.02.007_bib19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","article-title":"The role of risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2018.02.007_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature01230","article-title":"Insights into DNA recombination from the structure of a RAD51-BRCA2 complex","volume":"420","author":"Pellegrini","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2018.02.007_bib21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.cell.2009.02.019","article-title":"The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51","volume":"136","author":"Carreira","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.clbc.2018.02.007_bib22","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","article-title":"Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population","volume":"33","author":"Song","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.02.007_bib23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4143\/crt.2016.433","article-title":"Identification of a novel BRCA1 pathogenic mutation in Korean patients following reclassification of BRCA1 and BRCA2 variants according to the ACMG standards and guidelines using relevant ethnic controls","volume":"49","author":"Park","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.clbc.2018.02.007_bib24","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1158\/0008-5472.CAN-09-4563","article-title":"Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays","volume":"70","author":"Lee","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2018.02.007_bib25","doi-asserted-by":"crossref","first-page":"dju091","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2018.02.007_bib26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1010679","article-title":"Association between body-mass index and risk of death in more than 1 million Asians","volume":"364","author":"Zheng","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2018.02.007_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa054017","article-title":"Body-mass index and mortality in Korean men and women","volume":"355","author":"Jee","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2018.02.007_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jamaoncol.2015.1546","article-title":"Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the Women's Health Initiative randomized clinical trials","volume":"1","author":"Neuhouser","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2018.02.007_bib29","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10549-012-2159-5","article-title":"Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer","volume":"134","author":"Kim","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2018.02.007_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4048\/jbc.2014.17.2.129","article-title":"Characteristics of BRCA1\/2 mutation-positive breast cancers in Korea: a comparison study based on multicenter data and the Korean Breast Cancer Registry","volume":"17","author":"Yu","year":"2014","journal-title":"J\u00a0Breast Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917307851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917307851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:45Z","timestamp":1761513405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820917307851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1526820917307851"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2018.02.007","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1\/2 Mutation Carriers","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}